Travoprost intraocular implant (Glaukos)

N/A

Report date: 2024/03/13 20:05:28

Base Information

Drug NameTravoprost intraocular implant (Glaukos)
Drug Alias NameiDose®TR
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin F2 alpha agonists
TargetsProstaglandin F2 alpha
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsGlaucoma, Open-AngleOcular Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2023/12/13
Country/TerritoryArmeniaUnited StatesPhilippines
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaukos Corp
China Registration ClassN/A

Develop Information

Active CompaniesGlaukos Corp
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleOcular Hypertension
Inactive IndicationsGlaucoma

Other Information

ATC CodeS01EE04
Related LinksWikipediaDrugBankKEGG